‘Generative AI On Roblox: Our Vision For The Future Of Creation’ – Roblox Blog Post
Today, 3:39 AM
https://blog.roblox.com/2023/02/generative-ai-roblox-vision-future-creation/
Today, Roblox provides creators with a platform that enables end-to-end tools, services, and support to help them build the most immersive 3D
What’s Up With Roblox? Benchmark Analyst Weighs In
Today, 3:39 AM
Roblox Corp (NYSE: RBLX) on Wednesday issued its fourth-quarter results for the fiscal year 2022, stirring up positive analyst chatter at Benchmark by showing impressive growth in key areas.
Morgan Stanley Maintains Underweight on Roblox, Raises Price Target to $26
Today, 3:39 AM
Morgan Stanley analyst Matthew Cost maintains Roblox (NYSE:RBLX) with a Underweight and raises the price target from $24 to $26.
DA Davidson Maintains Buy on Roblox, Raises Price Target to $55
Today, 3:39 AM
DA Davidson analyst Franco Granda maintains Roblox (NYSE:RBLX) with a Buy and raises the price target from $50 to $55.
Wedbush Maintains Neutral on Roblox, Raises Price Target to $37
Today, 3:39 AM
Wedbush analyst Nick McKay maintains Roblox (NYSE:RBLX) with a Neutral and raises the price target from $32 to $37.
Goldman Sachs Maintains Sell on Roblox, Raises Price Target to $21
Today, 3:39 AM
Goldman Sachs analyst Kevin Kumar maintains Roblox (NYSE:RBLX) with a Sell and raises the price target from $19 to $21.
Needham Maintains Buy on Roblox, Raises Price Target to $53
Today, 3:39 AM
Needham analyst Bernie McTernan maintains Roblox (NYSE:RBLX) with a Buy and raises the price target from $42 to $53.
Top 15 Trending Stocks On WallStreetBets As Of Wednesday, Feb. 15, 2023 (Via Swaggy Stocks)
Today, 3:39 AM
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Google (GOOG)
Airbnb (ABNB)
Nvidia (NVDA)
Palantir (PLTR)
Apple (AAPL)
Taiwan Semiconductor Manufacturing
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Today, 3:39 AM
Gainers
Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.